Triampyzine

Triampyzine
Clinical data
Other names	(Dimethylamino)trimethylpyrazine; W-3976B; W3976-B; W-3976-B; W3976B; 3,5,6-Trimethylampyzine
Identifiers
	IUPAC name N,N,3,5,6-pentamethylpyrazin-2-amine;
CAS Number	6503-95-3 ; 7082-30-6 (sulfate);
PubChem CID	23484;
ChemSpider	21956;
UNII	OPV4883241;
ChEMBL	ChEMBL2111165;
CompTox Dashboard (EPA)	DTXSID90863888 ;
Chemical and physical data
Formula	C9H15N3
Molar mass	165.240 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(N=C(C(=N1)C)N(C)C)C;
	InChI InChI=1S/C9H15N3/c1-6-7(2)11-9(12(4)5)8(3)10-6/h1-5H3; Key:RKPVUWPGCFGDJO-UHFFFAOYSA-N;

Triampyzine (INNTooltip International Nonproprietary Name), also known as triampyzine sulfate (USANTooltip United States Adopted Name; developmental code name W-3976B) in the case of the sulfate salt, as (dimethylamino)trimethylpyrazine, or as 3,5,6-trimethylampyzine, is a drug described as an anticholinergic and antisecretory agent which was never marketed. It was first described in the literature by 1966. The drug is the 3,5,6-trimethylated derivative of ampyzine (W-3580B), which is also a drug and is, conversely, described as a "central stimulant".